(Q44451316)

English

Gemfibrozil reduces release of tumor necrosis factor-alpha in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gemfibrozil reduces release of tumor necrosis factor-alpha in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

author name string

Shui-Ping Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Hui-Jun Ye

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Hong-Nian Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sai Nie

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Quan-Zhong Li

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinica Chimica Acta

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

332

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

61-67

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Inflammatory markers in coronary artery disease: let prevention douse the flames

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Tumor necrosis factor-alpha in human arterial wall with atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Accumulation of LDL in rat arteries is associated with activation of tumor necrosis factor-alpha expression

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Peroxisome proliferator-activated receptors in inflammation control

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Impairment of endothelial function after a high-fat meal in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Captopril inhibits the production of tumor necrosis factor-alpha by human mononuclear cells in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Molecular link between cholesterol, cytokines and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Human monocytes/macrophages release TNF-alpha in response to Ox-LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Preactivated peripheral blood monocytes in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900123-2

7 January 2021

Identifiers

10.1016/S0009-8981(03)00123-2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44451316&oldid=2024510687"